Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Sortiert nach
    Datensatz exportieren als...
  • BibTeX
Guadecitabine (SGI-110): an investigational drug for the treatment of myelodysplastic syndrome and acute myeloid leukemia
Expert opinion on investigational drugs, 2019-10, Vol.28 (10), p.835-849
2019
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol
Blood advances, 2022-02, Vol.6 (4), p.1193-1206
2022
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Autoimmune disorders are common in myelodysplastic syndrome patients and confer an adverse impact on outcomes
Annals of hematology, 2018-08, Vol.97 (8), p.1349-1356
2018
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Outcomes and effect of somatic mutations after erythropoiesis stimulating agents in patients with lower-risk myelodysplastic syndromes
Therapeutic advances in hematology, 2024, Vol.15, p.20406207231218157-20406207231218157
2024
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Dichotomization of the new revised international prognostic scoring system for a better clinical stratification of patients with myelodysplastic syndromes
Leukemia & lymphoma, 2019-05, Vol.60 (6), p.1522-1527
2019
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Comparative study to evaluate the wound healing efficacy of topical formulations containing Triticum aestivum L. (Triticum vulgare) in a native human skin model
Surgical & cosmetic dermatology, 2022, Vol.14
2022
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Molecular and cytogenetic characterization of myelodysplastic syndromes in cell-free DNA
Blood advances, 2022-05, Vol.6 (10), p.3178-3188
2022
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Iadademstat Combination with Azacitidine Is a Safe and Effective Treatment in First Line Acute Myeloid Leukemia. Final Results of the Alice Trial
Blood, 2022-11, Vol.140 (Supplement 1), p.1711-1713
2022
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Multiple TET2 Mutations As a New Biological Clue for Differentiating Oligomonocytic Chronic Myelomonocytic Leukemia from Myelodysplastic Syndromes
Blood, 2021-11, Vol.138 (Supplement 1), p.1530-1530
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Clinical Outcomes of Oligomonocytic Chronic Myelomonocytic Leukemia (OM-CMML) and Predictive Factors of Evolution of OM-CMML into Overt Chronic Myelomonocytic Leukemia (CMML)
Blood, 2021-11, Vol.138 (Supplement 1), p.1533-1533
2021
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Iadademstat in Combination with Azacitidine Generates Robust and Long Lasting Responses in AML Patients (ALICE Trial)
Blood, 2021-11, Vol.138 (Supplement 1), p.3376-3376
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Generation of a New Prognostic Index for Chronic Myelomonocytic Leukemia (CMML) Based on Peripheral Blood Assessment
Blood, 2019-11, Vol.134 (Supplement_1), p.4262-4262
2019
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Molecular Characterization and Clinical Outcomes of Young Adult Patients (≤45 years old) with Philadelphia-Negative Myeloproliferative Neoplasms
Blood, 2020-11, Vol.136 (Supplement 1), p.13-14
2020
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Non-Invasive Genetic Profiling and Monitoring in Myelodysplastic Syndromes
Blood, 2021-11, Vol.138 (Supplement 1), p.2599-2599
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Oligomonocytic Chronic Myelomonocytic Leukemia (O-CMML) and Chronic Myelomonocytic Leukemia (CMML) Show Similar Clinical, Morphological, Immunophenotypic and Molecular Features
Blood, 2019-11, Vol.134 (Supplement_1), p.4266-4266
2019
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
High Diagnostic Utility of Flow Cytometry Based Peripheral Blood Monocyte Subset Analysis, CD56 and CD2 Expression in Chronic Myelomonocytic Leukemia (CMML)
Blood, 2019-11, Vol.134 (Supplement_1), p.5437-5437
2019
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Validation of the European Leukemianet 2017 Prognostic Classification for Patients with De Novo Acute Myeloid Leukemia Treated with a Risk-Adapted Protocol (CETLAM 2012)
Blood, 2020-11, Vol.136 (Supplement 1), p.31-32
2020
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
A Revised International Prognostic Scoring System of 3.5 Points Stratifies Patients with Myelodysplastic Syndromes into 2 Risk Categories
Blood, 2020-11, Vol.136 (Supplement 1), p.9-10
2020
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Prospective Population-Based Analysis of Characteristics and Therapy Options in AML: The Case of Catalonia (PERIS Project)
Blood, 2020-11, Vol.136 (Supplement 1), p.32-33
2020
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Risk-Adapted Intensive Chemotherapy for Primary ACUTE Myeloid Leukemia during the Last 25 YEARS: Increase in Complete Remission RATE, Hematopoietic Cell Transplantation Access and Decrease in Relapse Incidence Have LED to Improved Survival
Blood, 2020-11, Vol.136 (Supplement 1), p.13-14
2020
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Final Results of the AML12 Trial of the Spanish Cetlam Group in Adults with Acute Myeloid Leukemia (AML) up to the Age of 70 Years: Risk Adapted Post-Remission Allocation Based on Genetic Data and Minimal Residual Disease
Blood, 2019-11, Vol.134 (Supplement_1), p.289-289
2019
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Daratumumab in transfusion‐dependent patients with low or intermediate‐1 risk myelodysplastic syndromes
American journal of hematology, 2021-04, Vol.96 (4), p.E111-E114
2021
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Use of newer prognostic indices for patients with myelodysplastic syndromes in the low and intermediate-1 risk categories: a population-based study
The Lancet. Haematology, 2015-06, Vol.2 (6), p.e260-e266
2015
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
An IPSS-R Cutpoint of 3 Stratified Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML) Patients (pts) into Two Risk Groups
Blood, 2017-12, Vol.130, p.5306-5306
2017
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Oligomonocytic and overt chronic myelomonocytic leukemia show similar clinical, genomic, and immunophenotypic features
Blood advances, 2020-10, Vol.4 (20), p.5285-5296
2020
Volltextzugriff (PDF)
1 – 25 von 43
Suche als RSS-Feed
Suchergebnisse filtern
Filter anzeigen